Blood–brain barrier dysfunction can contribute to pharmacoresistance of seizures. Issue 8 (3rd July 2014)
- Record Type:
- Journal Article
- Title:
- Blood–brain barrier dysfunction can contribute to pharmacoresistance of seizures. Issue 8 (3rd July 2014)
- Main Title:
- Blood–brain barrier dysfunction can contribute to pharmacoresistance of seizures
- Authors:
- Salar, Seda
Maslarova, Anna
Lippmann, Kristina
Nichtweiss, Julia
Weissberg, Itai
Sheintuch, Liron
Kunz, Wolfram S.
Shorer, Zamir
Friedman, Alon
Heinemann, Uwe - Abstract:
- <abstract abstract-type="main" id="epi12713-abs-0001"> <title>Summary</title> <sec id="epi12713-sec-0001" sec-type="section"> <title>Objective</title> <p>We tested the hypothesis that interstitial albumin can contribute to pharmacoresistance, which is common among patients with focal epilepsies. These patients often present with an open blood–brain barrier (BBB), resulting in diffusion of drug‐binding albumin into the brain interstitial space.</p> </sec> <sec id="epi12713-sec-0002" sec-type="section"> <title>Methods</title> <p>Seizure‐like events (SLEs) induced by 100 μ<sc>m</sc> 4‐aminopyridine (4‐AP) were monitored using extracellular field potential recordings from acute rat entorhinal cortex–hippocampus slices. Effects of standard antiepileptic drugs (phenytoin, valproic acid, carbamazepine, and phenobarbital) were studied in the presence of albumin applied acutely or by intraventricular injection. Unbound antiepileptic drugs (AEDs) were detected by ultrafiltration and high‐performance liquid chromatography (HPLC).</p> </sec> <sec id="epi12713-sec-0003" sec-type="section"> <title>Results</title> <p>Contrary to the absence of albumin, conventional AEDs failed to suppress SLEs in the rat entorhinal cortex in the presence of albumin. This effect was partially caused by buffering of phenytoin and carbamazepine (CBZ) by albumin. Increasing CBZ concentration from 50 μ<sc>m</sc> to 100 μ<sc>m</sc> resulted in block of SLEs. In slices obtained from animals that were pretreated<abstract abstract-type="main" id="epi12713-abs-0001"> <title>Summary</title> <sec id="epi12713-sec-0001" sec-type="section"> <title>Objective</title> <p>We tested the hypothesis that interstitial albumin can contribute to pharmacoresistance, which is common among patients with focal epilepsies. These patients often present with an open blood–brain barrier (BBB), resulting in diffusion of drug‐binding albumin into the brain interstitial space.</p> </sec> <sec id="epi12713-sec-0002" sec-type="section"> <title>Methods</title> <p>Seizure‐like events (SLEs) induced by 100 μ<sc>m</sc> 4‐aminopyridine (4‐AP) were monitored using extracellular field potential recordings from acute rat entorhinal cortex–hippocampus slices. Effects of standard antiepileptic drugs (phenytoin, valproic acid, carbamazepine, and phenobarbital) were studied in the presence of albumin applied acutely or by intraventricular injection. Unbound antiepileptic drugs (AEDs) were detected by ultrafiltration and high‐performance liquid chromatography (HPLC).</p> </sec> <sec id="epi12713-sec-0003" sec-type="section"> <title>Results</title> <p>Contrary to the absence of albumin, conventional AEDs failed to suppress SLEs in the rat entorhinal cortex in the presence of albumin. This effect was partially caused by buffering of phenytoin and carbamazepine (CBZ) by albumin. Increasing CBZ concentration from 50 μ<sc>m</sc> to 100 μ<sc>m</sc> resulted in block of SLEs. In slices obtained from animals that were pretreated with intraventricular albumin application 24 h prior to experiment, CBZ suppressed SLEs similar to control slices. We also found that application of serum‐like electrolytes transformed SLEs into late recurrent discharges (LRDs), which were no longer responding to CBZ.</p> </sec> <sec id="epi12713-sec-0004" sec-type="section"> <title>Significance</title> <p>A dysfunctional BBB with acute extravasation of serum albumin into the brain's interstitial space could contribute to pharmacoresistance. In such instances, choice of an AED with low albumin binding affinity may help in seizure control.</p> <p>A PowerPoint slide summarizing this article is available for download in the Supporting Information section <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/epi.12713/supinfo" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">here</ext-link>.</p> </sec> </abstract> … (more)
- Is Part Of:
- Epilepsia. Volume 55:Issue 8(2014:Aug.)
- Journal:
- Epilepsia
- Issue:
- Volume 55:Issue 8(2014:Aug.)
- Issue Display:
- Volume 55, Issue 8 (2014)
- Year:
- 2014
- Volume:
- 55
- Issue:
- 8
- Issue Sort Value:
- 2014-0055-0008-0000
- Page Start:
- 1255
- Page End:
- 1263
- Publication Date:
- 2014-07-03
- Subjects:
- Epilepsy -- Periodicals
616.853 - Journal URLs:
- http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=epi ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/epi.12713 ↗
- Languages:
- English
- ISSNs:
- 0013-9580
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3793.700000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3876.xml